AI-generated summary
The authors studied streptozotocin-induced type 1 diabetic rats to test whether low-level laser therapy at 904 nm could reverse allodynia and protect peripheral nerve fibers. They report that four sessions reversed allodynia and protected nerve damage in these rats. The authors note that biochemical effects still need further evaluation.
- Who or what was studied
- Male Wistar rats with streptozotocin-induced type 1 diabetes
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The study was conducted in rats and the abstract states that biochemical effects must be further evaluated to confirm the biological effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 23 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Neuropathy, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.